Author:
Goldstein M.,Meller E.,Adler C. H.
Reference19 articles.
1. Adler, C.H., Meller, E. and Goldstein, M. (1985). Recovery of alpha2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Eur. J. Pharmacol. 116, 1178–178.
2. Ariens, E.J., Van Rossum, J.M. and Koopman, P.C. ( 1960). Receptor reserve and threshold phenomena. Arch. Int. Pharmacodyn Ther. 127, 459–478.
3. Cambridge, D. (1981). UK-14,304, a potent and selective alpha2-agonist for the characterization of alpha-adrenoreceptor subtypes. Eur. J. Pharmacol. 72, 413–415.
4. Carlsson, A. (1983). Dopamine receptor agonists: intrinsic activity vs. state of receptor. J. Neur. Trans. 57, 309–315.
5. Clark, D., Hjorth, S. and Carlsson, A. (1985). Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neur. Trans. 62, 171–207.